financetom
Business
financetom
/
Business
/
Varex Imaging Shares Down 16% After China Launches Anti-Dumping Investigation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Varex Imaging Shares Down 16% After China Launches Anti-Dumping Investigation
Apr 4, 2025 9:29 AM

12:05 PM EDT, 04/04/2025 (MT Newswires) -- Varex Imaging ( VREX ) shares fell 16% in recent Friday trading after it said the China Ministry of Commerce announced an anti-dumping investigation into imports of some medical CT X-ray tubes originating in the US and India.

The company has yet to receive any formal notice of the MOFCOM investigation, according to a regulatory filing.

Varex stated that it produces medical CT X-ray tubes and inserts in the US and ships them to China but is not involved in making these in India.

The company added that it believes it complies with competition laws and will cooperate in the investigation should it receive a formal notice.

Price: 8.64, Change: -1.68, Percent Change: -16.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AbbVie Secures European Marketing Clearance for Giant Cell Arteritis Treatment Rinvoq
AbbVie Secures European Marketing Clearance for Giant Cell Arteritis Treatment Rinvoq
Apr 8, 2025
03:23 AM EDT, 04/08/2025 (MT Newswires) -- AbbVie ( ABBV ) said Tuesday that the European Commission granted marketing authorization to giant cell arteritis treatment Rinvoq for adult patients. The approval was based on results from a phase 3 trial, which met its primary and key secondary endpoints, the company said. The drug has been previously approved in seven other...
Ventas Insider Sold Shares Worth $3,165,935, According to a Recent SEC Filing
Ventas Insider Sold Shares Worth $3,165,935, According to a Recent SEC Filing
Apr 8, 2025
03:22 AM EDT, 04/08/2025 (MT Newswires) -- Debra A Cafaro, Director, Chairman and Chief Executive Officer, on April 03, 2025, sold 44,551 shares in Ventas ( VTR ) for $3,165,935. Following the Form 4 filing with the SEC, Cafaro has control over a total of 1,145,695 common shares of the company, with 1,145,695 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/740260/000074026025000117/xslF345X05/wk-form4_1744066448.xml ...
US is starting to look like an emerging market after tariff shock, Euronext CEO says
US is starting to look like an emerging market after tariff shock, Euronext CEO says
Apr 8, 2025
PARIS, April 8 (Reuters) - The United States is starting to resemble an emerging market more than a developed country, Euronext's CEO Stephane Boujnah said on Tuesday as financial markets remained volatile after the imposition of sweeping U.S. tariffs. Fear exists all over, the head of the pan-European stock exchange operator told France Inter radio. The country (United States) is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved